Although nonalcoholic steatohepatitis (NASH) has generally been considered
a benign condition, the increasing prevalence and severity of obesity has h
eightened concerns about the frequency with which NASH progresses to end-st
age liver disease. The aim of this study is to determine the frequency clin
ical features, and posttransplantation history of decompensated liver disea
se secondary to NASH. The frequency of NASH as a cause of end-stage liver d
isease was prospectively determined in patients evaluated for liver transpl
antation. NASH was considered to be the primary cause of liver disease in p
atients who had histological evidence of steatohepatitis and in whom chroni
c liver diseases other than NASH were excluded. Posttransplantation histolo
gical characteristics were also determined in patients with NASH and compar
ed with those of patients with pretransplantation diagnoses of cholestatic
liver diseases, alcoholic disease, and hepatitis C. Of 1,207 patients evalu
ated for liver transplantation during the study period, 31 patients (2.6%)
had NASH as the primary cause of liver disease. In the same period, 546 liv
er transplantations were performed, 16 of which (2.9%) were for end-stage d
isease secondary to NASH. Posttransplantation steatosis was seen in 60% of
transplant recipients with NASH versus 5% of those with cholestatic disease
,; 15% of those with alcoholic disease, and 15% of those with hepatitis C.
Steatohepatitis recurred in 33% of transplant recipients with NASH, with pr
ogression to cirrhosis in 12.5%. NASH can progress to end-stage liver disea
se in a minority of affected patients and was the primary cause of liver di
sease in 2.9% of patients evaluated for Liver transplantation at oar center
, Recurrence of steatosis and NASH is frequent and can be severe after live
r transplantation.